Virco is a biotech company locate in Mechelen, Belgium. It provides a quantitative phenotype prediction for HIV resistance testing. The prediction is achieved by performing a search in a database of genotype-phenotype pairs and matching the mutations in the database with those of the sample of the patient (Nearest neighbor search). A phenotype is predicted which provides information on the resistance of the virus to treatment.